Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from MedX Health ( (TSE:MDX) ).
MedX Health Corp. has appointed Dr. Paul J. Matts, a renowned skin scientist and former R&D Vice President at Procter & Gamble, as a Strategic Advisor. Dr. Matts’ extensive experience in skin optics and sun protection will enhance MedX’s mission to advance early skin cancer detection and develop new skin assessment technologies. His appointment is expected to strengthen MedX’s scientific foundation and support the company’s goal of providing accessible skin cancer screening solutions.
More about MedX Health
MedX Health Corp., based in Ontario, Canada, is a leader in non-invasive skin assessment and teledermatology. The company offers proprietary SIAscopy® technology integrated into the DermSecure® platform, which allows for pain-free, accurate imaging of skin lesions for rapid dermatologist review. MedX’s products are approved for use in several countries including Canada, the U.S., Australia, and the European Union.
Average Trading Volume: 150,921
Technical Sentiment Signal: Sell
Current Market Cap: C$21.13M
For an in-depth examination of MDX stock, go to TipRanks’ Overview page.